DaVita HealthCare Partners Inc. (NYSE:DVA) has been assigned an average rating of “Hold” from the sixteen ratings firms that are presently covering the firm. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $73.27.

DVA has been the subject of a number of analyst reports. Jefferies Group reiterated a “buy” rating and set a $70.00 target price (down from $86.00) on shares of DaVita HealthCare Partners in a report on Saturday, November 19th. Bank of America Corp. reiterated a “hold” rating and set a $68.00 target price on shares of DaVita HealthCare Partners in a report on Monday, November 21st. SunTrust Banks Inc. set a $66.00 target price on shares of DaVita HealthCare Partners and gave the stock a “hold” rating in a report on Thursday, October 13th. Zacks Investment Research upgraded shares of DaVita HealthCare Partners from a “strong sell” rating to a “hold” rating in a report on Friday, November 4th. Finally, TheStreet lowered shares of DaVita HealthCare Partners from a “buy” rating to a “hold” rating in a report on Monday, August 8th.

DaVita HealthCare Partners (NYSE:DVA) opened at 63.33 on Wednesday. The stock has a market cap of $12.50 billion, a P/E ratio of 18.46 and a beta of 1.00. DaVita HealthCare Partners has a 52 week low of $54.50 and a 52 week high of $78.77. The stock has a 50 day moving average price of $60.43 and a 200-day moving average price of $69.33.

DaVita HealthCare Partners (NYSE:DVA) last posted its earnings results on Wednesday, November 2nd. The company reported $0.95 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.93 by $0.02. The company earned $3.73 billion during the quarter, compared to analyst estimates of $3.72 billion. DaVita HealthCare Partners had a net margin of 4.92% and a return on equity of 16.16%. DaVita HealthCare Partners’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.12 earnings per share. On average, equities analysts anticipate that DaVita HealthCare Partners will post $3.78 EPS for the current fiscal year.

WARNING: “Brokerages Set DaVita HealthCare Partners Inc. (DVA) Target Price at $73.27” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2016/11/26/brokerages-set-davita-healthcare-partners-inc-dva-target-price-at-73-27.html.

Institutional investors have recently added to or reduced their stakes in the company. Cacti Asset Management LLC increased its position in shares of DaVita HealthCare Partners by 6.3% in the third quarter. Cacti Asset Management LLC now owns 4,305 shares of the company’s stock worth $280,000 after buying an additional 255 shares in the last quarter. Speece Thorson Capital Group Inc. increased its position in shares of DaVita HealthCare Partners by 1.4% in the second quarter. Speece Thorson Capital Group Inc. now owns 181,101 shares of the company’s stock worth $14,003,000 after buying an additional 2,560 shares in the last quarter. Financial Engines Advisors L.L.C. increased its position in shares of DaVita HealthCare Partners by 22.3% in the second quarter. Financial Engines Advisors L.L.C. now owns 36,142 shares of the company’s stock worth $2,794,000 after buying an additional 6,579 shares in the last quarter. State Board of Administration of Florida Retirement System increased its position in shares of DaVita HealthCare Partners by 19.7% in the second quarter. State Board of Administration of Florida Retirement System now owns 277,939 shares of the company’s stock worth $21,490,000 after buying an additional 45,749 shares in the last quarter. Finally, Westpac Banking Corp increased its position in shares of DaVita HealthCare Partners by 30.4% in the second quarter. Westpac Banking Corp now owns 9,485 shares of the company’s stock worth $733,000 after buying an additional 2,213 shares in the last quarter. 86.14% of the stock is owned by institutional investors.

About DaVita HealthCare Partners

DaVita Inc, formerly DaVita HealthCare Partners Inc, is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.

5 Day Chart for NYSE:DVA

Receive News & Stock Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related stocks with our FREE daily email newsletter.